Lewi P J, Colpaert F C
Psychopharmacology (Berl). 1976 Sep 17;49(2):219-24. doi: 10.1007/BF00427294.
Clinical, pharmacologic, and biochemical profiles of antidepressant drugs have been analyzed statistically. A method derived from multivariate statistics separates mere drug potency from the spectral information contained in the profiles. The dimensionality of the spectra is also reduced and this results in a diagram of associations and dissociations between the antidepressants and their scales of observation. The spectra of antidepressants show three poles which have been labeled as D (desipraminelike), A (amitriptylinelike), and M (MAOI). Clinical spectra agree better between one another than various pharmacologic spectra do. Monoamine oxidase inhibitors are readily differentiated from the tricyclic compounds. The latter appear in the sequence: desipramine, nortriptyline, imipramine, and amitriptyline. This sequence can also be reproduced from biochemical spectra of central and peripheral blockade of norepinephrine and serotonin reuptake.
已对抗抑郁药物的临床、药理和生化特征进行了统计分析。一种源自多元统计的方法将单纯的药物效力与特征中包含的光谱信息区分开来。光谱的维度也有所降低,这产生了一张抗抑郁药与其观察量表之间关联和分离的图表。抗抑郁药的光谱显示出三个极点,分别标记为D(地昔帕明样)、A(阿米替林样)和M(单胺氧化酶抑制剂)。临床光谱之间的一致性比各种药理光谱之间的一致性更好。单胺氧化酶抑制剂很容易与三环化合物区分开来。后者按以下顺序出现:地昔帕明、去甲替林、丙咪嗪和阿米替林。这个顺序也可以从去甲肾上腺素和5-羟色胺再摄取的中枢和外周阻断的生化光谱中重现。